{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T03:41:40Z","timestamp":1708141300088},"reference-count":32,"publisher":"Japanese Society of Internal Medicine","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,2,15]]},"DOI":"10.2169\/internalmedicine.1929-23","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T22:11:56Z","timestamp":1687903916000},"page":"521-526","source":"Crossref","is-referenced-by-count":0,"title":["Shift in Dominance from Blocking to Stimulating Type of Thyrotropin Receptor Antibodies, Resulting in Conversion from Hypothyroidism to Hyperthyroidism during Late Pregnancy"],"prefix":"10.2169","volume":"63","author":[{"given":"Keiichi","family":"Kamijo","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kamijo Thyroid Clinic, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Smith BR, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 17: 923-938, 2007.","DOI":"10.1089\/thy.2007.0239"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zakaria M, McKenzie JM, Banovac K. Clinical significance of assay of thyroid stimulating antibody in Graves' disease. Ann Intern Med 93: 28-32, 1980.","DOI":"10.7326\/0003-4819-93-1-28"},{"key":"3","unstructured":"3. Kamijo K, Arioka H, Kawasaki Y, Higuchi Y. Correlation between serological diagnosis and pathological diagnosis of Hashimoto's thyroiditis-especially pertaining to studies on TPOAb by CLIA (Bayer Medical Ltd). Jpn J Med Phar Sci 48: 73-79, 2002 (in Japanese)."},{"key":"4","unstructured":"4. Kamijo K, Kawasaki K, Arioka H, Higuchi Y. Fundamental and clinical evaluation of serum anti-TgAb concentrations determined by CLIA using Chemilumi ACS-antiTgAb kit (Bayer Medical). Jpn J Med Pharm Sci 48: 73-79, 2002 (in Japanese)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kamijo K. Painless thyroiditis with thyrotropin receptor-blocking and receptor-stimulating autoantibodies. Intern Med 58: 3121-3123, 2019.","DOI":"10.2169\/internalmedicine.3212-19"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kamijo K. TSH-receptor antibody measurement in patients with various thyrotoxicosis and Hashimoto's thyroiditis: a comparison of two two-step assays, coated plate ELISA using porcine TSH-receptor and coated tube radioassay using human recombinant TSH-receptor. Endocrine J 50: 113-116, 2003.","DOI":"10.1507\/endocrj.50.113"},{"key":"7","unstructured":"7. Kamijo K, Togashi K. ECLIA TRAb and Mc4-TSAb. J Jpn Thyroid Assoc 2: 11-15, 2011 (in Japanese)."},{"key":"8","unstructured":"8. Kamijo K, Togashi K. Development of more sensitive bioassay of TSAb due to the modificationof conventional assay and its measurement in M22-TRAb-seronegative Graves' patients. Ann Thyroid Res 1: 5-10, 2014."},{"key":"9","unstructured":"9. Kamijo K, Murayama H, Togashi K. Fundamental studies on bioassay for TBAb using porcine thyroid cells. Jpn J Med Pharm Sci 73: 595-602, 2016."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kamijo K, Nagata A, Sato Y. Clinical significance of a sensitive assay for thyroid-stimulating antibodies in Graves' disease using polyethylene glycol at high concentration and porcine thyroid cells. Endocrine J 46: 397-403, 1999.","DOI":"10.1507\/endocrj.46.397"},{"key":"11","unstructured":"11. Kamijo K, Hoshina M, Doi K, Kawasaki A. Fundamental and clinical studies on BIOSENSOR TSAb YAMASA. Jpn J Med Pharm Sci 79: 1199-1207, 2022 (in Japanese)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kamijo K. Study on cut-off value setting for differential diagnosis between Graves' disease and painless thyroiditis using the TRAb (Elecsys TRAb) measurement via the fully automated electrochemiluminescence immunoassay system. Endocrinol J 57: 895-902, 2010.","DOI":"10.1507\/endocrj.K10E-199"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Zakaria M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulalting antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab 57: 1036-1040, 1983.","DOI":"10.1210\/jcem-57-5-1036"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tamai H, Kasagi K, Takaichi Y, et al. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. J Clin Endocrinol Metab 69: 49-53, 1989.","DOI":"10.1210\/jcem-69-1-49"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Inomata H, Tsuyusaki T, Sasaki N, Tamaru K, Nimi H, Nakajima H. A patient with Graves' disease who developed hypothyroidism associated thyroid stimulation blocking immunoglobulin during anti-thyroid drug therapy. Endocrine J 35: 379-384, 1988.","DOI":"10.1507\/endocrj1954.35.379"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shigemasa C, Mitani Y, Taniguchi S, et al. Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism. Arch Intern Med 150: 1105-1109, 1990.","DOI":"10.1001\/archinte.150.5.1105"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Chung H-K, Kim WB, Park DJ, Kohn LD, Tahara K, Cho BY. Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies. Thyroid 9: 393-399, 1999.","DOI":"10.1089\/thy.1999.9.393"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Tagami T, Hirosima-Hamanaka K, Umakoshi H, et al. Experimental reproduction of dynamic fluctuation of TSH receptor-binding antibodies between stimulation and inhibition. J Endocrinol Soc 3: 2361-2373, 2019.","DOI":"10.1210\/js.2019-00012"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Kim WB, Chung HK, Park YJ, Tahara K, Kohn LD, Cho BY. The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. Thyroid 10: 579-586, 2000.","DOI":"10.1089\/thy.2000.10.579"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Diana T, Krause J, Olibo PD, et al. Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease. Clin Exp Immunol 189: 304-309, 2017.","DOI":"10.1111\/cei.12980"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kraiem Z, Baron E, Kahana L, Sadeh O, Sheinfeld M. Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycle of transition from hyp to hyperthyroidism and back to hypothyroidism. Clin Endocrinol 36: 211-216, 1992.","DOI":"10.1111\/j.1365-2265.1992.tb00960.x"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kasagi K, Takeda K, Goshi K, et al. Presence of both stimulating and blocking types of TSH-receptor antibodies in sera from three patients with primary hypothyroidism. Clin Endocrinol 32: 253-260, 1990.","DOI":"10.1111\/j.1365-2265.1990.tb00861.x"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Lu R, Burrman KD, Jonklaas J. Transient Graves' hyperthyroidism during pregnancy in a patient with Hashimoto's hypothyroidism. Thyroid 15: 725-729, 2005.","DOI":"10.1089\/thy.2005.15.725"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Anderson SL, Olsen J, Carl\u00e9 A, Lauberg P. Hyperthyroidism incidence fluctuates widely in and around pregnancy and is at variance with some other autoimmune diseases: a Danish population-based study. J Clin Endocrinol Metab 100: 1164-1171, 2015.","DOI":"10.1210\/jc.2014-3588"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Payrat JA, Chikh K, Bossard N, et al. Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism. Eur J Endocrinol 171: 451-460, 2014.","DOI":"10.1530\/EJE-14-0254"},{"key":"26","doi-asserted-by":"crossref","unstructured":"27. Takasu N, Matsusita M. Changes of TSH-stimulation blocking antibody (TBAb) and thyroid stimulating antibody (TSAb) over 10 years in 34 TSBAb-positive patients with hypothyroidism and in 98 TSAb-positive patients with hyperthyroidism: reevaluation of TSBAb and TSAb in TSH-receptor-antibody (TRAb)-positive patients. J Thyroid Res 2012: 182176, 2012.","DOI":"10.1155\/2012\/182176"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18: 267-288, 2004.","DOI":"10.1016\/S1521-690X(04)00015-6"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanism. Nat Rev Endocrinol 6: 311-318, 2020.","DOI":"10.1038\/nrendo.2010.46"},{"key":"29","doi-asserted-by":"crossref","unstructured":"30. Amino N, Izumi Y, Hidaka Y, et al. No increase of blocking type-thyrotropin receptor antibodies during pregnancy patients with Graves' disease. J Clin Endocrinol Metab 88: 5871-5874, 2003.","DOI":"10.1210\/jc.2003-030971"},{"key":"30","first-page":"30","volume":"31","author":"N Amino","year":"1978","unstructured":"31. Amino N, Kuro R, Tanizawa O, et al. Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid disease. Clin Exp Immunol 31: 30-37, 1978.","journal-title":"Clinical & Experimental Immunology","ISSN":"http:\/\/id.crossref.org\/issn\/0009-9104","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"32. Glinoer D, Riahi M, Gr\u00fcn J-P, Kinghert J. Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79: 197-204, 1994.","DOI":"10.1210\/jcem.79.1.8027226"},{"key":"32","doi-asserted-by":"crossref","unstructured":"33. Furmaniak J, Sanders J, Mlguel RN, Smith BR. Mechanism of actionof TSHR autoantibodies. Horm Metab Res 47: 735-752, 2015.","DOI":"10.1055\/s-0035-1559648"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_1929-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T03:17:59Z","timestamp":1708139879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/4\/63_1929-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.1929-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"article-number":"1929-23"}}